Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Finance · ·
$31.83
▼ $0.54 (-1.7%)
Market data updated: 10/01 08:32 AM
Fundamentals updated: 10/01/2026
News analyzed: 10/01/2026
Market Cap
$3.08B
Day Range
$31.39 - $32.55
52-Week Range
$28.58 - $36.27
Beta
—
Next Earnings
26.10.2026
Support
$31.39
Resistance
$36.27
+4.6% (1Y)
Strengths: 5/22 factors positiveRisk: Medium
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🔴 Bearish
Technical Trend
🔴 Bearish
Insiders
🔴 Bearish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Leverage risk
Debt/equity: 0.04
Risk
Biggest negative driver
Calmar Ratio (return vs. drawdown)
Calmar: 0.48 (3y annualized return 13.8% / max drawdown 28.8%)
Risk
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 3 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 3
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
43
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
60
Quality
55
Value
50
Momentum
9
Risk
48
Sentiment
62
Fundamental
50
Institutional
0
Stocks with a similar DNA right now
This stock hasn't been analyzed by StockIQAI's movement engine yet — coverage is still expanding. Check back soon.
Recent media coverage of Seacoast Banking Corporation of Florida has centered on its financial performance and investor sentiment. The company’s Q2 2026 earnings call highlighted strong loan growth, stable margins, and solid asset quality, with adjusted EPS beating estimates at $0.61. Analysts like Piper Sandler maintained a neutral outlook while slightly raising their price target to $35.5. Discussions also included its potential benefits from sustained higher long-term interest rates, positioning it favorably among financial stocks.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about Seacoast Banking Corporation of Florida. News trend score: 62. Reason: 4 of the last 7 articles are positive, versus 2 negative.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
20
🎯 Conviction (vs. Emotion)
52
Psychology
72
Fundamentals
50
Technical
9
Valuation
50
The price is holding at a real, documented historical support/resistance level (a 50-day high or low).
The stock is moving in lockstep with its peers at the same intensity, rather than on its own data.
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
Extreme momentum, price far above its moving average, and a large premium over fair value.
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
Price (3M)
-4%
Market Narrative
40
Fundamental Reality
52
Narrative Gap
-12
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Samuel Armstrong Nelson — 100/100
🔴 Weakest match
Thorstein Veblen — 14/100
🗣️ Why do they disagree?
This stock sparks a sharp divide between methodologies that prioritize long-term fundamentals and those skeptical of its immediate appeal. The most bullish models—like those of Nelson, Smith, and Bagehot (despite data limitations)—highlight its cyclical positioning, potential for decade-long holding, or favorable market conditions, suggesting it aligns with patient, buy-and-hold strategies. Meanwhile, value-oriented investors like Graham and Marks see it as reasonably priced but not compelling enough for aggressive bets, while Fisher and Veblen dismiss it outright due to insufficient fundamentals or perceived speculative growth. The contrast between the top-tier scores (100s) and the low-end verdicts (14–35) underscores a clash between optimism about structural tailwinds and caution about valuation or market timing.
Walter Bagehot
Lombard Street (1873)
🟢 100
Not enough balance-sheet data for a real Bagehot read
Key question
Does this company have enough liquidity to survive real stress?
⚠️ Partial data for this stock — score is less reliable — Data availability: 25%
Fact → Principle → Simulation
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟢 100
Cycle position looks favorable — closer to oversold than overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟢 100
Looks like a real 'buy and hold for a decade' candidate
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟢 93
No obvious signs of crowd mania
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🟢 79
The kind of quiet compounder a patient holder could actually stick with
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🟢 71
Attractive to a Defensive Graham Investor
Key question
Where is my margin of safety?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟢 69
Risk appears reasonably priced — no obvious cycle-timing red flag
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟢 68
Looks early-to-mid cycle, not overextended
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟢 66
Reasonable capital-preservation profile
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟡 64
No clear edge either way
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🟡 50
Not enough fundamentals data for a real Fisher read
Key question
How exceptional is this business, really?
⚠️ Partial data for this stock — score is less reliable — Data availability: 0%
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 42
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🔴 35
Negative trend — against Livermore's core rule of trading with the trend
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🔴 35
Not statistically cheap enough for the Enterprising Investor's looser safety bar
Key question
Is the stock statistically cheap enough to justify the extra risk?
⚠️ Partial data for this stock — score is less reliable — Data availability: 45%
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🔴 30
Doesn't clear Lynch's growth-at-a-reasonable-price bar
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🔴 14
Pattern Veblen would flag as growth pursued for its own sake
Key question
Is management building real value, or just building itself?
⚠️ Partial data for this stock — score is less reliable — Data availability: 45%
Fact → Principle → Simulation
Based on the last 288 trading days, calculated from real price data. Click an indicator for details and a chart.
🔴 Most indicators support a downtrend (0 bullish · 11 bearish · 0 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear downtrend with no defined trading range in the period examined.
High confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
—
Operating Margin
—
Net Margin
—
EBITDA Margin
—
ROE
5.3%
ROA
0.7%
ROIC
—
EPS
$1.59
Cash
$388.55M
Total Debt
$112.76M
Current Ratio
—
Debt/Equity
0.04
אין נתונים היסטוריים זמינים.
אין נתונים היסטוריים זמינים.
Total dividend per share paid each year, over the last 5 years.
| Ex-Dividend Date | Amount per Share |
|---|---|
| 15.9.2026 | $0.190 |
| 15.6.2026 | $0.190 |
| 13.3.2026 | $0.190 |
| 15.12.2025 | $0.190 |
| 15.9.2025 | $0.180 |
| 13.6.2025 | $0.180 |
| 14.3.2025 | $0.180 |
| 13.12.2024 | $0.180 |
| 13.9.2024 | $0.180 |
| 14.6.2024 | $0.180 |
| 14.3.2024 | $0.180 |
| 14.12.2023 | $0.180 |
How is Fair Value calculated? →
Not enough cash-flow data to calculate a DCF model for this stock.
Book Value per Share
$30.44
Tangible Book Value per Share (Tangible NAV)
$16.63
Sentiment based on basic keywords (not AI) — 4 positive, 1 neutral, 2 negative out of the last 7 articles.
SeekingAlpha · 25.9.2026
Yahoo · 21.9.2026
Benzinga · 30.7.2026
SeekingAlpha · 29.7.2026
SeekingAlpha · 29.7.2026
ChartMill · 28.7.2026
Benzinga · 28.7.2026
Seacoast Banking Corporation of Florida (SBCF) currently has a StockIQ AI score of 43/100, rated "Weak". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
SBCF currently scores 43/100 (Weak) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
SBCF's technical score is 9/100, which currently reads as bearish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Debt/equity: 0.04; Earnings per share (EPS) growth: 10.6%; Net income growth: 19.7%.
Based on the real signals StockIQ computed: Calmar: 0.48 (3y annualized return 13.8% / max drawdown 28.8%); Price is below the 50-day average; Price is below the 200-day average.
Yes — SBCF has a real recorded dividend payment history on StockIQ. See the Dividends section on this page for the actual per-share amounts and dates.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 2 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| HUDSON DENNIS S III | Open Market Sale | 16.9.2026 | 206,869 | -12,000 | $34.15 |
| Kleffel Juliette | Exercise of Derivative Securities | 27.8.2026 | 93,152 | +14,831 | $28.69 |
| Kleffel Juliette | Exercise of Derivative Securities | 27.8.2026 | 0 | -14,831 | — |
| Kleffel Juliette | Open Market Sale | 27.8.2026 | 78,321 | -14,831 | $34.31 |
| Shaffer Charles M | Exercise of Derivative Securities | 4.8.2026 | 202,657 | +28,544 | $28.69 |
| Shaffer Charles M | Tax Withholding in Shares | 4.8.2026 | 176,806 | -25,851 | $35.47 |
| Shaffer Charles M | Exercise of Derivative Securities | 4.8.2026 | 0 | -28,544 | $35.47 |
| HUDSON DENNIS S III | Grant/Award from Employer | 31.7.2026 | 218,869 | +2,015 | $34.74 |
| HUDSON DALE M | Grant/Award from Employer | 31.7.2026 | 34,061 | +2,015 | $34.74 |
| FOGAL CHRISTOPHER E | Grant/Award from Employer | 31.7.2026 | 34,763 | +2,015 | $34.74 |
| CULBRETH H GILBERT JR | Grant/Award from Employer | 31.7.2026 | 51,998 | +2,015 | $34.74 |
| ROSSIN THOMAS E | Grant/Award from Employer | 31.7.2026 | 34,061 | +2,015 | $34.74 |
| ARCZYNSKI DENNIS J | Grant/Award from Employer | 31.7.2026 | 15,331 | +2,015 | $34.74 |
| Monserrat Alvaro | Grant/Award from Employer | 31.7.2026 | 25,793 | +2,015 | $34.74 |
| GOEBEL MARYANN | Grant/Award from Employer | 31.7.2026 | 33,729 | +2,015 | $34.74 |
| Bradley Jacqueline Lynette | Grant/Award from Employer | 31.7.2026 | 30,964 | +2,015 | $34.74 |
| Lipstein Robert J | Grant/Award from Employer | 31.7.2026 | 10,627 | +2,015 | $34.74 |
| Kay Kathleen B | Grant/Award from Employer | 31.7.2026 | 2,047 | +2,015 | $34.74 |
| DEXTER TRACEY | Exercise of Derivative Securities | 31.7.2026 | 46,031 | +1,650 | $31.15 |
| DEXTER TRACEY | Exercise of Derivative Securities | 31.7.2026 | 1,192 | -1,650 | $31.15 |
| SHEAROUSE JOSEPH B III | Grant/Award from Employer | 31.7.2026 | 12,815 | +2,015 | $34.74 |
| Arriola Eduardo J | Grant/Award from Employer | 31.7.2026 | 4,259 | +2,015 | $34.74 |
| GRIFFIN MICHAEL E | Grant/Award from Employer | 31.7.2026 | 2,115 | +2,015 | $34.74 |
| MOORE RANDOLPH A III | Grant/Award from Employer | 31.7.2026 | 2,015 | +2,015 | $34.74 |
| CULBRETH H GILBERT JR | Grant/Award from Employer | 9.7.2026 | 49,983 | +390 | $31.66 |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
5,186,407 shares short as of 2026-09-15 · vs. 4,725,965 on 2026-08-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
65.0% of trading volume this week was short selling, vs. 60.2% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology